ARCHIVES

This month’s 8-page Business & Regulatory Report included in this issue.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001